860795-47-7

Basic information

• Product Name: 6-O-(4-azido-2,3-di-O-benzyl-4,6-dideoxy-α-D-glucopyranosyl)-3',4'-di-O-benzyl-1-N-[(S)-4-(benzyloxycarbonylamino)-2-hydroxybutanoyl]-3,2',3'-triazidoneamine
• Synonyms: 6-O-(4-azido-2,3-di-O-benzyl-4,6-dideoxy-α-D-glucopyranosyl)-3',4'-di-O-benzyl-1-N-[(S)-4-(benzyloxycarbonylamino)-2-hydroxybutanoyl]-3,2',3'-triazidoneamine
• CAS NO: 860795-47-7
• Molecular Weight: 1167.25
• Mol File: 860795-47-7.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: 6-O-(4-azido-2,3-di-O-benzyl-4,6-dideoxy-α-D-glucopyranosyl)-3',4'-di-O-benzyl-1-N-[(S)-4-(benzyloxycarbonylamino)-2-hydroxybutanoyl]-3,2',3'-triazidoneamine(CAS DataBase Reference)
• NIST Chemistry Reference: 6-O-(4-azido-2,3-di-O-benzyl-4,6-dideoxy-α-D-glucopyranosyl)-3',4'-di-O-benzyl-1-N-[(S)-4-(benzyloxycarbonylamino)-2-hydroxybutanoyl]-3,2',3'-triazidoneamine(860795-47-7)
• EPA Substance Registry System: 6-O-(4-azido-2,3-di-O-benzyl-4,6-dideoxy-α-D-glucopyranosyl)-3',4'-di-O-benzyl-1-N-[(S)-4-(benzyloxycarbonylamino)-2-hydroxybutanoyl]-3,2',3'-triazidoneamine(860795-47-7)

Safety Data

• Hazardous Substances Data: 860795-47-7(Hazardous Substances Data)

Upstream product

• 688744-65-2 1,3,2’,6’-tetrazido-5,6-O-cyclohexylidene neamine 
• 549501-27-1 3′,4′-di-O-benzyl-1,3,2′,6′-tetraazidoneamine 
• 369631-91-4 phenyl 4-C-azido-2,3-di-O-benzyl-4,6-dideoxy-1-thio-β-D-glucopyranoside 
• 100-39-0 benzyl bromide 
• 860795-45-5 6-O-(4-azido-2,3-di-O-benzyl-4,6-dideoxy-α-D-glucopyranosyl)-3',4'-di-O-benzyl-1-N-tert-butoxycarbonyl-3,2',3'-triazidoneamine 
• 860795-33-1 3',4'-di-O-benzyl-5,6-di-O-(p-chlorobenzoyl)-1,3,2',3'-tetraazidoneamine 
• 860795-43-3 3',4'-di-O-benzyl-1-N-tert-butoxycarbonyl-3,2',3'-triazidoneamine 
• 40371-50-4 S-4-benzyloxycarbonylamino-2-hydroxybutyric acid 

Relevant articles and documents

Tuning the regioselectivity of the staudinger reaction for the facile synthesis of kanamycin and neomycin class antibiotics with N-1 modification

(Chemical Equation Presented) A novel method for achieving the desired regioselective reduction of the N-1 azido group on a tetraazidoneamine has been developed that leads to the synthesis of both kanamycin and neomycin class antibiotics bearing N-1 modif